DNMT3A and graft versus host disease: To investigate the cause of the enhanced GVHD severity observed in mice receiving Dnmt3a-KO BMT, we next examined whether Dnmt3a gene deletion influenced T cell migration to secondary lymphoid organs (SLOs) early after infusion.